These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18020194)

  • 1. The engineers of human souls & academia.
    Healy D
    Epidemiol Psichiatr Soc; 2007; 16(3):205-11. PubMed ID: 18020194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-opting psychiatry: the alliance between academic psychiatry and the pharmaceutical industry.
    Moncrieff J
    Epidemiol Psichiatr Soc; 2007; 16(3):192-6. PubMed ID: 18020190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collaborations between academic psychiatry and the pharmaceutical industry: a perspective from industry.
    Tohen M
    Epidemiol Psichiatr Soc; 2007; 16(3):197-8. PubMed ID: 18020191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does brand differentiate pharmaceuticals?
    Bednarik J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction?
    Barbui C; Tansella M
    Epidemiol Psichiatr Soc; 2007; 16(3):189-91. PubMed ID: 18020189
    [No Abstract]   [Full Text] [Related]  

  • 6. Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
    Mohl PC
    Acad Psychiatry; 2005; 29(2):215-21. PubMed ID: 15937270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration.
    Varley CK
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):292-4. PubMed ID: 17630861
    [No Abstract]   [Full Text] [Related]  

  • 10. Symposium review: drug discovery, development and clinical research in academia.
    Vlaar CP; Hernández L
    P R Health Sci J; 2009 Sep; 28(3):268-73. PubMed ID: 19715120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970.
    Tobbell DA
    Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partnership between academia and industry for drug discovery in Alzheimer's disease.
    Ivinson AJ; Lane R; May PC; Hosford DA; Carrillo MC; Siemers ER
    Alzheimers Dement; 2008 Mar; 4(2):80-8. PubMed ID: 18631952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faculties of health sciences and the pharmaceutical industry: an effective partnership.
    Forrest JB
    CMAJ; 1994 Nov; 151(9):1320-2. PubMed ID: 7954182
    [No Abstract]   [Full Text] [Related]  

  • 14. Private industry, academia team up on HIV vaccine.
    Sweeney R; Lapp T
    Am Fam Physician; 2000 Aug; 62(3):483. PubMed ID: 10950207
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of the pharmaceutical industry in medical education in psychiatry.
    Lazarus A
    Acad Psychiatry; 2006; 30(1):40-4. PubMed ID: 16473993
    [No Abstract]   [Full Text] [Related]  

  • 16. [An analysis of advertisements for psychotropic drugs in the Dutch Journal of Psychiatry ('Tijdschrift voor Psychiatrie')].
    Vandereycken W; Kuyken K
    Tijdschr Psychiatr; 2009; 51(6):407-11. PubMed ID: 19517371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational aspects of interactions with the pharmaceutical industry.
    Balon R
    Acad Psychiatry; 2010; 34(2):90-1. PubMed ID: 20224012
    [No Abstract]   [Full Text] [Related]  

  • 18. Redefining the dermatologist-academy-industry relationship: an open letter.
    Craft N
    J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):536-7; discussion 537. PubMed ID: 15761445
    [No Abstract]   [Full Text] [Related]  

  • 19. Debunking myths in physician-industry conflicts of interest.
    Lichter PR
    Am J Ophthalmol; 2008 Aug; 146(2):159-71. PubMed ID: 18538299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Scientific journals and the pharmaceutical industry].
    van Harten PN; van Hezewijk WJ
    Tijdschr Psychiatr; 2009; 51(6):413-5. PubMed ID: 19517372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.